Bioequivalence of LB80380 Free Base and Maleate Salt Tablets
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The study is to compare pharmacokinetics of LB80331 and LB80317, which are the metabolites of
LB80380, after a single oral administration of LB80380 free base 150 mg (60 mg + 90 mg)
tablet or LB80380 maleate tablet 183 mg (150 mg as a free base) in healthy male subjects.